Clinical trial results support use of weekly extended-release buprenorphine for treatment of opioid use disorder during pregnancy NIH-supported study shows this treatment resulted in higher rates of illicit opioid abstinence than current standard of care.

Clinical trial results support use of weekly extended-release buprenorphine for treatment of opioid use disorder during pregnancy NIH-supported study shows this treatment resulted in higher rates of illicit opioid abstinence than current standard of care. https://www.nih.gov/news-events/news-releases/clinical-trial-results-support-use-weekly-extended-release-buprenorphine-treatment-opioid-use-disorder-during-pregnancy The Helping to End Addiction Long-term® Initiative The NIH HEAL Initiative® is an NIH-wide effort to improve prevention and treatment strategies for opioid misuse and addiction and to enhance pain management.​ https://www.nih.gov/heal